Aurobindo Pharma gets USFDA approval for diarrhoea and allergy drugs
Advertisement
Hyderabad: Aurobindo Pharma said it has received final approval from the USFDA to manufacture and market two drugs used for treating diarrhoea and allergy.
The first, Loperamide Hydrochloride tablet, is used to control symptoms of diarrhoea, including travelers' diarrhoea. The approved product has an estimated market size of USD 9.7 million for the 12 months ending October 2015, according to IMS Health.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.